DOI: 10.1111/apt.16311 ISSN:

Editorial: stratifying risk of adverse outcomes in cirrhosis—the Hepquant SHUNT test. Authors' reply

Sumeet K. Asrani, Gregory T. Everson
  • Pharmacology (medical)
  • Gastroenterology
  • Hepatology
Show PDF Cite

LINKED CONTENT

This article is linked to Fallahzadeh et al and Maan & Sonneveld papers. To view these articles, visit https://doi.org/10.1111/apt.16283 and https://doi.org/10.1111/apt.16299

More from our Archive